Effects of a single dose of N-carbamylglutamate on the rate of ureagenesis
- PMID: 19660971
- PMCID: PMC2784258
- DOI: 10.1016/j.ymgme.2009.07.010
Effects of a single dose of N-carbamylglutamate on the rate of ureagenesis
Erratum in
- Mol Genet Metab. 2010 Apr;99(4):440
Abstract
We studied the effect on ureagenesis of a single dose of N-carbamylglutamate (NCG) in healthy young adults who received a constant infusion (300 min) of NaH(13)CO(3). Isotope ratio-mass spectrometry was used to measure the appearance of label in [(13)C]urea. At 90 min after initiating the H(13)CO3-infusion each subject took a single dose of NCG (50 mg/kg). In 5/6 studies the administration of NCG increased the formation of [(13)C]urea. Treatment with NCG significantly diminished the concentration of blood alanine, but not that of glutamine or arginine. The blood glucose concentration was unaffected by NCG administration. No untoward side effects were observed. The data indicate that treatment with NCG stimulates ureagenesis and could be useful in clinical settings of acute hyperammonemia of various etiologies.
Figures




Similar articles
-
N-carbamylglutamate markedly enhances ureagenesis in N-acetylglutamate deficiency and propionic acidemia as measured by isotopic incorporation and blood biomarkers.Pediatr Res. 2008 Aug;64(2):213-7. doi: 10.1203/PDR.0b013e318179454b. Pediatr Res. 2008. PMID: 18414145 Free PMC article. Clinical Trial.
-
N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia.Pediatrics. 2010 Jul;126(1):e208-14. doi: 10.1542/peds.2010-0008. Epub 2010 Jun 21. Pediatrics. 2010. PMID: 20566609 Free PMC article. Clinical Trial.
-
Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes.Mol Genet Metab. 2017 Mar;120(3):198-206. doi: 10.1016/j.ymgme.2016.12.002. Epub 2016 Dec 8. Mol Genet Metab. 2017. PMID: 28007335 Free PMC article.
-
Augmenting ureagenesis in patients with partial carbamyl phosphate synthetase 1 deficiency with N-carbamyl-L-glutamate.J Pediatr. 2014 Aug;165(2):401-403.e3. doi: 10.1016/j.jpeds.2014.04.012. Epub 2014 May 29. J Pediatr. 2014. PMID: 24880889 Free PMC article. Clinical Trial.
-
Recovery of (13)CO2 during rest and exercise after [1-(13)C]acetate, [2-(13)C]acetate, and NaH(13)CO3 infusions.Am J Physiol Endocrinol Metab. 2001 Oct;281(4):E683-92. doi: 10.1152/ajpendo.2001.281.4.E683. Am J Physiol Endocrinol Metab. 2001. PMID: 11551844
Cited by
-
Real-World Experience of Carglumic Acid for Methylmalonic and Propionic Acidurias: An Interim Analysis of the Multicentre Observational PROTECT Study.Drugs R D. 2024 Mar;24(1):69-80. doi: 10.1007/s40268-023-00449-z. Epub 2024 Jan 10. Drugs R D. 2024. PMID: 38198106 Free PMC article.
-
Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized controlled trial.BMC Pediatr. 2019 Jun 13;19(1):195. doi: 10.1186/s12887-019-1571-y. BMC Pediatr. 2019. PMID: 31196016 Free PMC article.
-
The neglected PCK1/glucagon (inter)action in nutrient homeostasis beyond gluconeogenesis: Disease pathogenesis and treatment.Mol Metab. 2025 Apr;94:102112. doi: 10.1016/j.molmet.2025.102112. Epub 2025 Feb 13. Mol Metab. 2025. PMID: 39954782 Free PMC article. Review.
-
Recurrent encephalopathy: NAGS (N-acetylglutamate synthase) deficiency in adults.Can J Neurol Sci. 2013 Jan;40(1):3-9. doi: 10.1017/s0317167100012877. Can J Neurol Sci. 2013. PMID: 23250120 Free PMC article. Review.
-
Measuring in vivo ureagenesis with stable isotopes.Mol Genet Metab. 2010;100 Suppl 1(Suppl 1):S37-41. doi: 10.1016/j.ymgme.2010.02.017. Epub 2010 Feb 26. Mol Genet Metab. 2010. PMID: 20338795 Free PMC article.
References
-
- Hall LM, Metzenberg RL, Cohen PP. Isolation and characterization of a naturally occurring cofactor of carbamyl phosphate biosynthesis. J Biol Chem. 1958;230:1013–1021. - PubMed
-
- Bachmann C, Colombo JP, Jaggi K. N-acetylglutamate synthetase (NAGS) deficiency: diagnosis, clinical observations and treatment. Adv Exp Med Biol. 1982;153:39–45. - PubMed
-
- Schubiger G, Bachmann C, Barben P, Colombo JP, Tonz O, Schupbach D. N-acetylglutamate synthetase deficiency: diagnosis, management and follow-up of a rare disorder of ammonia detoxication. Eur J Pediatr. 1991;150:353–356. - PubMed
-
- Caldovic L, Morizono H, Panglao MG, Cheng SF, Packman S, Tuchman M. Null mutations in the N-acetylglutamate synthase gene associated with acute neonatal disease and hyperammonemia. Hum Genet. 2003;112:364–368. - PubMed
-
- Caldovic L, Morizono H, Panglao MG, Lopez GY, Shi D, Summar ML, Tuchman M. Late onset N-acetylglutamate synthase deficiency caused by hypomorphic alleles. Hum Mutat. 2005;25:293–298. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DK064913/DK/NIDDK NIH HHS/United States
- DK53761/DK/NIDDK NIH HHS/United States
- R56 DK053761/DK/NIDDK NIH HHS/United States
- U54 HD061221/HD/NICHD NIH HHS/United States
- RR00240/RR/NCRR NIH HHS/United States
- R01 DK053761/DK/NIDDK NIH HHS/United States
- RR019453/RR/NCRR NIH HHS/United States
- NS054900/NS/NINDS NIH HHS/United States
- R01 HD058567/HD/NICHD NIH HHS/United States
- P01 NS054900/NS/NINDS NIH HHS/United States
- U54 RR019453/RR/NCRR NIH HHS/United States
- DK47870/DK/NIDDK NIH HHS/United States
- M01 RR000240/RR/NCRR NIH HHS/United States
- HD26979/HD/NICHD NIH HHS/United States
- HD058567/HD/NICHD NIH HHS/United States
- P30 HD026979/HD/NICHD NIH HHS/United States
- R01 NS034900/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical